Logo du site
  • English
  • Français
  • Se connecter
Logo du site
  • English
  • Français
  • Se connecter
  1. Accueil
  2. Université de Neuchâtel
  3. Notices
  4. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC
 
  • Details
Options
Vignette d'image

Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC

Auteur(s)
Zhong, Weimin
Gern, Lise 
Institut de biologie 
Stehle, Thomas
Museteanu, Crisan
Kramer, Michael
Wallich, Reinhard
Simon, Markus M
Date de parution
1999
In
European Journal of Immunology
Vol.
3
No
29
De la page
946
A la page
957
Mots-clés
  • Lyme disease
  • therapeutic vaccination
  • outer surface protein C
  • original antigenic sin
  • OUTER SURFACE-PROTEIN
  • LYME-DISEASE AGENT
  • MONOCLONAL-ANTIBODIES
  • PROTECTIVE ANTIBODIES
  • VACCINATION
  • CHALLENGE
  • INDUCTION
  • IMMUNITY
  • STRAINS
  • RODENTS
  • Lyme disease

  • therapeutic vaccinati...

  • outer surface protein...

  • original antigenic si...

  • OUTER SURFACE-PROTEIN...

  • LYME-DISEASE AGENT

  • MONOCLONAL-ANTIBODIES...

  • PROTECTIVE ANTIBODIES...

  • VACCINATION

  • CHALLENGE

  • INDUCTION

  • IMMUNITY

  • STRAINS

  • RODENTS

Résumé
Vaccination with outer surface protein A (OspA) of Borrelia burgdorferi prevents subsequent infection and disease in both laboratory animals and humans with high efficacy. OspA-based immunity, however, does not affect established infection due to the loss of OspA expression in the vertebrate host. We show here that repeated passive transfer of mouse and/or rabbit immune sera to recombinant GST-OspC fusion protein resulted in a dose-dependent resolution (1) of fully established arthritis and carditis as well as infection in needle-challenged C.B-17 SCID and (2) of infection in both experimentally and tick-infected BALB/c mice. Unexpectedly, active immunization of disease-susceptible AKR/N mice with GST-OspC only led to prevention but not resolution of disease and infection, in spite of high serum titers of OspC-specific Ab and the expression of ospC in tissue-derived spirochetes. The data suggest that the efficacy of OspC antibody-mediated immunity depends on the immunological history of the recipient and/or environment-dependent regulation of OspC surface expression by spirochetes in vivo. The results encourage further attempts to develop therapeutic vaccination protocols against Lyme disease.
Identifiants
https://libra.unine.ch/handle/123456789/11853
Type de publication
journal article
google-scholar
Présentation du portailGuide d'utilisationStratégie Open AccessDirective Open Access La recherche à l'UniNE Open Access ORCIDNouveautés

Service information scientifique & bibliothèques
Rue Emile-Argand 11
2000 Neuchâtel
contact.libra@unine.ch

Propulsé par DSpace, DSpace-CRIS & 4Science | v2022.02.00